NCT06856291View on ClinicalTrials.gov

Response to Semaglutide in Non-diabetic Obese Patients With Varying Degrees of Insulin Resistance

RecruitingOBSERVATIONAL

Enrollment

40

Participants

Timeline

Start Date

March 15, 2025

Primary Completion Date

August 31, 2026

Study Completion Date

August 31, 2026

Conditions

Obesity and Obesity-related Medical ConditionsObesity and OverweightInsulin Sensitivity/ResistanceSemaglutide

Trial Locations (1)

5001

RECRUITING

Cantonal Hospital Aarau, Aarau

All Listed Sponsors

lead

ETH Zurich

OTHER